Targeted drug delivery: designing nanocarriers for improved therapeutic action
Abstract
, functional chemical/group, antibodies, or peptides) that bind to overexpressed receptors on diseased cells, ensuring high local drug concentration. This precision significantly boosts therapeutic efficacy while minimally affecting healthy tissues, leading to fewer side effects. This review provides an in-depth examination of TDD, highlighting how nanocarriers are essential in achieving precision and improving therapeutic outcomes. It explores the diverse strategies and suitable materials utilized to guide therapeutic agents specifically to disease sites while minimizing systemic toxicity.
Fields of Study & Subjects
Nanoparticle-Based Drug Delivery
Nanoplatforms for cancer theranostics
RNA Interference and Gene Delivery
Publication details
- Journal / source
- Chemical Communications
- Publisher
- Royal Society of Chemistry (RSC)
- Volume
- 62
- Issue
- 23
- Pages
- 6232–6256
- Publication date
- 1 January 2026
- Language
- EN